Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry.
Atrial fibrillation
Device-related thrombus
Left atrial appendage closure
Stroke
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
16
03
2022
accepted:
05
07
2022
pubmed:
19
7
2022
medline:
3
11
2022
entrez:
18
7
2022
Statut:
ppublish
Résumé
Data on Device-related Thrombus (DRT) after left atrial appendage closure (LAAC) remain scarce. This study aimed to investigate risk factors for DRT from centers reporting to the EUROC-DRT registry. We included 537 patients (112 with DRT and 425 without DRT) who had undergone LAAC between 12/2008 and 04/2019. Baseline and implantation characteristics, anti-thrombotic treatment and clinical outcomes were compared between both groups in uni- and multivariate analyses. Additional propensity-score matching (PSM) was conducted to focus on the role of implantation characteristics. Patients with DRT showed higher rates of previous stroke/transient ischemic attack (TIA) (49.1% vs. 34.7%, p < 0.01), spontaneous echocardiographic contrast (SEC) (44.9% vs. 27.7%, p < 0.01) and lower left atrial appendage (LAA) peak emptying velocity (35.4 ± 18.5 vs. 42.4 ± 18.0 cm/s, p = 0.02). Occluders implanted in DRT patients were larger (25.5 ± 3.8 vs. 24.6 ± 3.5 mm, p = 0.03) and implanted deeper in the LAA (mean depth: 7.6 ± 4.7 vs. 5.7 ± 4.7 mm, p < 0.01). Coverage of the appendage ostium was achieved less often in DRT patients (69.5% vs. 81.5%, p < 0.01), while DRT patients were less frequently on oral anticoagulation (7.1% vs. 16.7%, p < 0.01). Multivariate analysis identified age, prior stroke/TIA and SEC as independent risk factors for DRT. After PSM, implantation depth was found to be predictive. Rates of stroke/TIA were higher in DRT patients (13.5% vs. 3.8%, Hazard Ratio: 4.21 [95%-confidence interval: 1.88-9.49], p < 0.01). DRT after LAAC is associated with adverse outcome and appears to be of multifactorial origin, depending on patient characteristics, anticoagulation regimen and device position.
Sections du résumé
BACKGROUND
BACKGROUND
Data on Device-related Thrombus (DRT) after left atrial appendage closure (LAAC) remain scarce. This study aimed to investigate risk factors for DRT from centers reporting to the EUROC-DRT registry.
METHODS
METHODS
We included 537 patients (112 with DRT and 425 without DRT) who had undergone LAAC between 12/2008 and 04/2019. Baseline and implantation characteristics, anti-thrombotic treatment and clinical outcomes were compared between both groups in uni- and multivariate analyses. Additional propensity-score matching (PSM) was conducted to focus on the role of implantation characteristics.
RESULTS
RESULTS
Patients with DRT showed higher rates of previous stroke/transient ischemic attack (TIA) (49.1% vs. 34.7%, p < 0.01), spontaneous echocardiographic contrast (SEC) (44.9% vs. 27.7%, p < 0.01) and lower left atrial appendage (LAA) peak emptying velocity (35.4 ± 18.5 vs. 42.4 ± 18.0 cm/s, p = 0.02). Occluders implanted in DRT patients were larger (25.5 ± 3.8 vs. 24.6 ± 3.5 mm, p = 0.03) and implanted deeper in the LAA (mean depth: 7.6 ± 4.7 vs. 5.7 ± 4.7 mm, p < 0.01). Coverage of the appendage ostium was achieved less often in DRT patients (69.5% vs. 81.5%, p < 0.01), while DRT patients were less frequently on oral anticoagulation (7.1% vs. 16.7%, p < 0.01). Multivariate analysis identified age, prior stroke/TIA and SEC as independent risk factors for DRT. After PSM, implantation depth was found to be predictive. Rates of stroke/TIA were higher in DRT patients (13.5% vs. 3.8%, Hazard Ratio: 4.21 [95%-confidence interval: 1.88-9.49], p < 0.01).
CONCLUSIONS
CONCLUSIONS
DRT after LAAC is associated with adverse outcome and appears to be of multifactorial origin, depending on patient characteristics, anticoagulation regimen and device position.
Identifiants
pubmed: 35849156
doi: 10.1007/s00392-022-02065-4
pii: 10.1007/s00392-022-02065-4
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1276-1285Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Références
Hildick-Smith D, Landmesser U, Camm AJ et al (2020) Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study. Eur Heart J 41:2894–2901. https://doi.org/10.1093/eurheartj/ehaa169
doi: 10.1093/eurheartj/ehaa169
pubmed: 32243499
pmcid: 7421773
Holmes DR, Reddy VY, Turi ZG et al (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534–542. https://doi.org/10.1016/S0140-6736(09)61343-X
doi: 10.1016/S0140-6736(09)61343-X
pubmed: 19683639
Cochet H, Iriart X, Sridi S et al (2018) Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study. Eur Heart J Cardiovasc Imaging 19:1351–1361. https://doi.org/10.1093/ehjci/jey010
doi: 10.1093/ehjci/jey010
pubmed: 29415203
Fauchier L, Cinaud A, Brigadeau F et al (2018) Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol 71:1528–1536. https://doi.org/10.1016/j.jacc.2018.01.076
doi: 10.1016/j.jacc.2018.01.076
pubmed: 29622159
Lempereur M, Aminian A, Saw J (2018) Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet. Catheter Cardiovasc Interv 92:E216–E217. https://doi.org/10.1002/ccd.27135
doi: 10.1002/ccd.27135
pubmed: 28544491
Sedaghat A, Schrickel J, Andrié R et al (2016) Thrombus formation after left atrial appendage occlusion with the amplatzer amulet device. JACC Clin Electrophysiol. https://doi.org/10.1016/j.jacep.2016.05.006
doi: 10.1016/j.jacep.2016.05.006
pubmed: 29759698
Dukkipati SR, Kar S, Holmes DR et al (2018) Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation 138:874–885. https://doi.org/10.1161/CIRCULATIONAHA.118.035090
doi: 10.1161/CIRCULATIONAHA.118.035090
pubmed: 29752398
Sedaghat A, Nickenig G, Schrickel JW et al (2021) Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. https://doi.org/10.1002/ccd.29458
doi: 10.1002/ccd.29458
Freixa X, Cepas-Guillen P, Flores-Umanzor E et al (2021) Pulmonary ridge coverage and device-related thrombosis after left atrial appendage occlusion. EuroIntervention 16:E1288–E1294. https://doi.org/10.4244/EIJ-D-20-00886
doi: 10.4244/EIJ-D-20-00886
pubmed: 33164895
Sedaghat A, Vij V, Al-Kassou B et al (2021) Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-Registry. Circ Cardiovasc Interv. https://doi.org/10.1161/circinterventions.120.010195
doi: 10.1161/circinterventions.120.010195
pubmed: 34003661
Aminian A, Schmidt B, Mazzone P et al (2019) Incidence, characterization, and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER amulet observational study. JACC Cardiovasc Interv 12:1003–1014. https://doi.org/10.1016/j.jcin.2019.02.003
doi: 10.1016/j.jcin.2019.02.003
pubmed: 31103540
Pracon R, Bangalore S, Dzielinska Z et al (2018) Device thrombosis after percutaneous left atrial appendage occlusion is related to patient and procedural characteristics but not to duration of postimplantation dual antiplatelet therapy. Circ Cardiovasc Interv 11:1–7. https://doi.org/10.1161/CIRCINTERVENTIONS.117.005997
doi: 10.1161/CIRCINTERVENTIONS.117.005997
Simard T, Jung RG, Lehenbauer K et al (2021) Predictors of device-related thrombus following percutaneous left atrial appendage occlusion. J Am Coll Cardiol 78:297–313. https://doi.org/10.1016/j.jacc.2021.04.098
doi: 10.1016/j.jacc.2021.04.098
pubmed: 34294267
Plicht B, Konorza TFM, Kahlert P et al (2013) Risk factors for thrombus formation on the amplatzer cardiac plug after left atrial appendage occlusion. JACC Cardiovasc Interv 6:606–613. https://doi.org/10.1016/j.jcin.2013.02.014
doi: 10.1016/j.jcin.2013.02.014
pubmed: 23787233
Rashid HN, Layland J (2021) Association between device-related thrombus and the neo-appendage with left-atrial appendage occlusion devices. Eur Heart J 42:1047–1048. https://doi.org/10.1093/eurheartj/ehaa803
doi: 10.1093/eurheartj/ehaa803
pubmed: 33167004
Mill J, Olivares AL, Arzamendi D et al (2020) Impact of flow dynamics on device-related thrombosis after left atrial appendage occlusion. Can J Cardiol 36:968.e13-968.e14. https://doi.org/10.1016/j.cjca.2019.12.036
doi: 10.1016/j.cjca.2019.12.036
Meier B (2018) What lies beneath left atrial appendage occlusion. Circulation 11:1–3. https://doi.org/10.1161/CIRCINTERVENTIONS.118.006360
doi: 10.1161/CIRCINTERVENTIONS.118.006360
Søndergaard L, Wong YH, Reddy VY et al (2019) Propensity-matched comparison of oral anticoagulation versus antiplatelet therapy after left atrial appendage closure with WATCHMAN. JACC Cardiovasc Interv 12:1055–1063. https://doi.org/10.1016/j.jcin.2019.04.004
doi: 10.1016/j.jcin.2019.04.004
pubmed: 31171282
Duthoit G, Silvain J, Marijon E et al (2020) Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study. Circ Cardiovasc Interv 13:e008481. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008481
doi: 10.1161/CIRCINTERVENTIONS.119.008481
pubmed: 32674675
Garot P, Iriart X, Aminian A et al (2020) Value of FEops HEARTguide patient-specific computational simulations in the planning of left atrial appendage closure with the Amplatzer Amulet closure device: rationale and design of the PREDICT-LAA study. Open Hear 7:1–5. https://doi.org/10.1136/openhrt-2020-001326
doi: 10.1136/openhrt-2020-001326